Air Products & Chemicals, Inc. APD
NYSE · stock · Industrial Inorganic Chemicals · website · IPO 1961-11-13
Air Products & Chemicals, Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.0B | $12.1B | $12.6B | $12.7B | $10.3B | $8.9B | $8.9B | $8.9B | $8.2B | $7.5B |
| Gross profit | — | — | — | — | — | $3.0B | $2.9B | $2.7B | $2.4B | $2.3B |
| R&D expense | $96.3M | $100.2M | $105.6M | $102.9M | $93.5M | $83.9M | $72.9M | $64.5M | $57.6M | $71.8M |
| SG&A expense | $906.1M | $942.4M | $957.0M | $900.6M | $828.4M | $775.9M | $750.0M | $760.8M | $713.5M | $683.8M |
| Operating income | -$877.0M | $4.5B | $2.5B | $2.3B | $2.3B | $2.2B | $2.1B | $2.0B | $1.4B | $1.5B |
| Interest expense | — | — | $177.5M | $128.0M | $141.8M | $109.3M | $137.0M | $130.5M | $120.6M | $115.2M |
| Income tax | -$94.3M | $944.9M | $551.2M | $500.8M | $462.8M | $478.4M | $480.1M | $524.3M | $260.9M | $432.6M |
| Net income | -$394.5M | $3.8B | $2.3B | $2.3B | $2.1B | $1.9B | $1.8B | $1.5B | $3.0B | $631.1M |
| EPS (diluted) | $-1.77 | $17.18 | $10.33 | $10.14 | $9.43 | $8.49 | $7.94 | $6.78 | $13.65 | $2.89 |
| Operating cash flow | $3.3B | $3.6B | $3.2B | $3.2B | $3.3B | $3.3B | $3.0B | $2.5B | $2.5B | $2.3B |
| Free cash flow | -$3.8B | -$3.1B | -$1.4B | $244.1M | $871.0M | $755.7M | $980.2M | $978.8M | $1.5B | $1.4B |
| Cash & equivalents | $1.9B | $3.0B | $1.6B | $2.7B | $4.5B | $5.3B | $2.2B | $2.8B | $3.3B | $1.3B |
| Inventory | $776.5M | $766.0M | $651.8M | $514.2M | $453.9M | $404.8M | $388.3M | $396.1M | $335.4M | $255.0M |
| Total assets | $41.1B | $39.6B | $32.0B | $27.2B | $26.9B | $25.2B | $18.9B | $19.2B | $18.5B | $18.0B |
| Total liabilities | $23.7B | $20.9B | $16.3B | $13.5B | $12.8B | $12.7B | $7.6B | $8.0B | $8.3B | $10.8B |
| Shareholders' equity | $17.3B | $18.7B | $15.7B | $13.7B | $14.1B | $12.4B | $11.4B | $11.2B | $10.2B | $7.2B |
Growth · year-over-year · Revenue CAGR 5.4%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -0.5% | -4.0% | -0.8% | +23.0% | +16.6% | -0.7% | -0.1% | +9.1% | +9.1% | -4.1% |
| Net income growth | -110.3% | +66.4% | +2.0% | +7.5% | +11.3% | +7.2% | +17.5% | -50.1% | +375.4% | -50.6% |
| EPS growth | -110.3% | +66.3% | +1.9% | +7.5% | +11.1% | +6.9% | +17.1% | -50.3% | +372.3% | -50.9% |
| Free cash flow growth | — | — | -682.0% | -72.0% | +15.3% | -22.9% | +0.1% | -34.3% | +10.2% | +52.7% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-09-30. Facts plus Stocktoria's own computed scores — not investment advice.